All Stories

  1. Climate, soil type, and geographic distribution of actinomycetoma cases in Northeast Mexico: A cross-sectional study

    Article • PLoS ONE, May 2020, PLOS

    Dr Lucio Vera-Cabrera

  2. Clinical characteristics and treatment of actinomycetoma in northeast Mexico: A case series

    Article • PLoS Neglected Tropical Diseases, February 2020, PLOS

    Dr Lucio Vera-Cabrera

  3. Genomic Changes Associated with the Loss of Nocardia brasiliensis Virulence in Mice after 200In VitroPassages

    Article • Infection and Immunity, June 2016, ASM Journals

    Dr Lucio Vera-Cabrera

  4. Mycobacterium lepromatosis Infections in Nuevo León, Mexico

    Article • Journal of Clinical Microbiology, March 2015, ASM Journals

    Dr Lucio Vera-Cabrera

  5. Genetic Diversity of Mycobacterium tuberculosis from Guadalajara, Mexico and Identification of a Rare Multidrug Resistant Beijing Genotype

    Article • PLoS ONE, February 2015, PLOS

    Dr Lucio Vera-Cabrera

  6. Red face and fungi infection

    Article • Clinics in Dermatology, November 2014, Elsevier

    Dr Lucio Vera-Cabrera

  7. Correlations between major risk factors and closely related Mycobacterium tuberculosis isolates grouped by three current enotyping procedures: a population-based study in northeast Mexico

    Article • Memórias do Instituto Oswaldo Cruz, September 2014, FapUNIFESP (SciELO)

    Dr Lucio Vera-Cabrera

  8. Comparative Mycobacterium tuberculosis Spoligotype Distribution in Mexico

    Article • Journal of Clinical Microbiology, May 2014, ASM Journals

    Dr Lucio Vera-Cabrera

  9. Draft Genome Sequence of Actinomadura madurae LIID-AJ290, Isolated from a Human Mycetoma Case

    Article • Genome Announcements, March 2014, ASM Journals

    Dr Lucio Vera-Cabrera

  10. HPLC Method for the Simultaneous Analysis of Fluoroquinolones and Oxazolidinones in Plasma

    Article • Journal of Chromatographic Science, March 2014, Oxford University Press (OUP)

    Dr Lucio Vera-Cabrera

  11. Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophages

    Article • Annals of Clinical Microbiology and Antimicrobials, January 2014, Springer Science + Business Media

    Dr Lucio Vera-Cabrera

  12. Current treatment for nocardia infections

    Article • Expert Opinion on Pharmacotherapy, October 2013, Informa Healthcare

    Dr Lucio Vera-Cabrera

  13. Hydrotherapy as a recovery strategy after exercise: a pragmatic controlled trial

    Article • BMC Complementary and Alternative Medicine, July 2013, Springer Science + Business Media

    Dr Lucio Vera-Cabrera, Dr Antonio I Cuesta-Vargas

  14. Complete Genome Sequence Analysis of Nocardia brasiliensis HUJEG-1 Reveals a Saprobic Lifestyle and the Genes Needed for Human Pathogenesis

    Article • PLoS ONE, June 2013, PLOS

    Dr Lucio Vera-Cabrera

  15. Coccidioidomycosis

    Article • Clinics in Dermatology, November 2012, Elsevier

    Dr Lucio Vera-Cabrera

  16. Nocardia brasiliensis Cell Wall Lipids Modulate Macrophage and Dendritic Responses That Favor Development of Experimental Actinomycetoma in BALB/c Mice

    Article • Infection and Immunity, July 2012, ASM Journals

    Dr Lucio Vera-Cabrera

  17. Actinomycetoma and advances in its treatment

    Article • Clinics in Dermatology, July 2012, Elsevier

    Dr Lucio Vera-Cabrera

  18. Host defenses in subcutaneous mycoses

    Article • Clinics in Dermatology, July 2012, Elsevier

    Dr Lucio Vera-Cabrera

  19. Complete Genome Sequence of Nocardia brasiliensis HUJEG-1

    Article • Journal of Bacteriology, April 2012, ASM Journals

    Dr Lucio Vera-Cabrera

  20. In VitroActivities of the New Antitubercular Agents PA-824 and BTZ043 against Nocardia brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, April 2012, ASM Journals

    Dr Lucio Vera-Cabrera

  21. Case of Diffuse Lepromatous Leprosy Associated with "Mycobacterium lepromatosis"

    Article • Journal of Clinical Microbiology, October 2011, ASM Journals

    Dr Lucio Vera-Cabrera

  22. Report: In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico

    Article • International Journal of Dermatology, August 2010, Wiley

    Dr Lucio Vera-Cabrera

  23. Evaluation of the Combined Therapy of DA-7218, a New Oxazolidinone, and Trimethoprim/ Sulfamethoxazole in the Treatment of Experimental Actinomycetoma by Nocardia brasiliensis

    Article • Current Drug Delivery, July 2010, Bentham Science Publishers

    Dr Lucio Vera-Cabrera

  24. Erratum: Corrigendum: Comparative genomic and phylogeographic analysis of Mycobacterium leprae

    Article • Nature Genetics, April 2010, Springer Science + Business Media

    Dr Lucio Vera-Cabrera

  25. In Vitro Activity of ACH-702, a New Isothiazoloquinolone, against Nocardia brasiliensis Compared with Econazole and the Carbapenems Imipenem and Meropenem Alone or in Combination with Clavulanic Acid

    Article • Antimicrobial Agents and Chemotherapy, March 2010, ASM Journals

    Dr Lucio Vera-Cabrera

  26. In Vitro Activity of a New Isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and Other Mycobacteria

    Article • Antimicrobial Agents and Chemotherapy, March 2010, ASM Journals

    Dr Lucio Vera-Cabrera

  27. Onychomycosis

    Article • Clinics in Dermatology, March 2010, Elsevier

    Dr Lucio Vera-Cabrera

  28. Effect of serial subculturing on the genetic composition and cytotoxic activity of Mycobacterium tuberculosis

    Article • Journal of Medical Microbiology, January 2010, Society for General Microbiology

    Dr Lucio Vera-Cabrera

  29. Mycobacterium tuberculosis Spoligotypes in Monterrey, Mexico

    Article • Journal of Clinical Microbiology, November 2009, ASM Journals

    Dr Lucio Vera-Cabrera

  30. Comparative genomic and phylogeographic analysis of Mycobacterium leprae

    Article • Nature Genetics, November 2009, Springer Science + Business Media

    Dr Lucio Vera-Cabrera

  31. Simplified amplified-fragment length polymorphism method for genotyping Mycobacterium tuberculosis isolates

    Article • Journal of Microbiological Methods, September 2009, Elsevier

    Dr Lucio Vera-Cabrera

  32. Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages

    Article • Journal of Antimicrobial Chemotherapy, August 2009, Oxford University Press (OUP)

    Dr Lucio Vera-Cabrera

  33. Efficacy of Ciprofloxacin and Moxifloxacin against Nocardia brasiliensis In Vitro and in an Experimental Model of Actinomycetoma in BALB/c Mice

    Article • Antimicrobial Agents and Chemotherapy, October 2008, ASM Journals

    Dr Lucio Vera-Cabrera

  34. Therapeutic Effect of a Novel Oxazolidinone, DA-7867, in BALB/c Mice Infected with Nocardia brasiliensis

    Article • PLoS Neglected Tropical Diseases, September 2008, PLOS

    Dr Lucio Vera-Cabrera

  35. Immune Response to Nocardia brasiliensis Extracellular Antigens in Patients with Mycetoma

    Article • Mycopathologia, February 2008, Springer Science + Business Media

    Dr Lucio Vera-Cabrera

  36. In Vivo Therapeutic Effect of Gatifloxacin on BALB/c Mice Infected with Nocardia brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, February 2008, ASM Journals

    Dr Lucio Vera-Cabrera

  37. Efficacy of DA-7218, a New Oxazolidinone Prodrug, in the Treatment of Experimental Actinomycetoma Produced by Nocardia brasiliensis

    Article • Molecules, January 2008, MDPI AG

    Dr Lucio Vera-Cabrera

  38. Cutaneous tuberculosis confirmed by PCR in three patients with biopsy and culture negative for mycobacterium tuberculosis

    Article • International Journal of Dermatology, July 2007, Wiley

    Dr Lucio Vera-Cabrera

  39. Use of a colorimetric assay to measure differences in cytotoxicity of Mycobacterium tuberculosis strains

    Article • Journal of Medical Microbiology, June 2007, Society for General Microbiology

    Dr Lucio Vera-Cabrera

  40. Simultaneous determination and validation of antimicrobials in plasma and tissue of actinomycetoma by high-performance liquid chromatography with diode array and fluorescence detection

    Article • Journal of Pharmaceutical and Biomedical Analysis, April 2007, Elsevier

    Dr Lucio Vera-Cabrera

  41. Mycetoma

    Article • Clinics in Dermatology, March 2007, Elsevier

    Dr Lucio Vera-Cabrera

  42. Genetic characterization of Mycobacterium tuberculosis clinical isolates with deletions in the plcA–plcB–plcC locus

    Article • Tuberculosis, January 2007, Elsevier

    Dr Lucio Vera-Cabrera

  43. In Vitro Activities of the Novel Oxazolidinones DA-7867 and DA-7157 against Rapidly and Slowly Growing Mycobacteria

    Article • Antimicrobial Agents and Chemotherapy, October 2006, ASM Journals

    Dr Lucio Vera-Cabrera

  44. In Vitro Activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, September 2006, ASM Journals

    Dr Lucio Vera-Cabrera

  45. Dermatophytoses in Monterrey, Mexico

    Article • Mycoses, March 2006, Wiley

    Dr Lucio Vera-Cabrera

  46. In Vitro Susceptibility of Mycobacterium tuberculosis Clinical Isolates to Garenoxacin and DA-7867

    Article • Antimicrobial Agents and Chemotherapy, October 2005, ASM Journals

    Dr Lucio Vera-Cabrera

  47. In Vitro and In Vivo Activities of Antimicrobials against Nocardia brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, March 2004, ASM Journals

    Dr Lucio Vera-Cabrera

  48. In Vitro Activities of New Quinolones and Oxazolidinones against Actinomadura madurae

    Article • Antimicrobial Agents and Chemotherapy, March 2004, ASM Journals

    Dr Lucio Vera-Cabrera

  49. In Vitro Activities of New Antimicrobials against Nocardia brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, January 2004, ASM Journals

    Dr Lucio Vera-Cabrera

  50. In Vitro Activity of PNU-100766 (Linezolid), a New Oxazolidinone Antimicrobial, against Nocardia brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, December 2001, ASM Journals

    Dr Lucio Vera-Cabrera

  51. Phospholipase Region of Mycobacterium tuberculosis Is a Preferential Locus for IS6110 Transposition

    Article • Journal of Clinical Microbiology, October 2001, ASM Journals

    Dr Lucio Vera-Cabrera

  52. Development of an enzyme-linked immunosorbent assay (ELISA) combined with a streptavidin-biotin and enzyme amplification method to detect anti-2,3-di-o-acyltrehalose (DAT) antibodies in patients with tubercolosis

    Article • Journal of Immunological Methods, December 1994, Elsevier

    Dr Lucio Vera-Cabrera